Man Group’s AbbVie ABBV Stock Holding History

Man Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.72M	Sell	35,500 -88,800	-71%	-$19.7M	0.01%	932
2025 Q4	$28.4M	Buy	124,300 +48,500	+64%	+$11M	0.05%	378
2025 Q3	$17.6M	Buy	75,800 +20,800	+38%	+$4.24M	0.03%	558
2025 Q2	$10.2M	Sell	55,000 -76,300	-58%	-$14.2M	0.02%	769
2025 Q1	$27.5M	Sell	131,300 -5,900	-4%	-$1.15M	0.07%	320
2024 Q4	$24.4M	Buy	137,200 +53,700	+64%	+$9.87M	0.06%	359
2024 Q3	$16.5M	Buy	83,500 +38,800	+87%	+$7.24M	0.04%	519
2024 Q2	$7.67M	Buy	44,700 +9,100	+26%	+$1.51M	0.02%	827
2024 Q1	$6.48M	Sell	35,600 -3,900	-10%	-$672K	0.02%	883
2023 Q4	$6.12M	Buy	+39,500	New	+$5.76M	0.02%	863
2023 Q3	–	Sell	-1,100	Closed	-$148K	–	1897
2023 Q2	$148K	Buy	+1,100	New	+$161K	﹤0.01%	1852
2023 Q1	–	Hold	0	–	–	–	2041

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Man Group's ABBV Position: Q1 2026 in Review

Man Group reduced its AbbVie (ABBV) stake by 1.9% in Q1 2026, selling an estimated $7.61M and leaving 1,774,415 shares worth $386M. The position accounts for 0.7% of the portfolio, ranked #12.

Man Group first reported a position in ABBV in Q1 2018 and has held it in 30 quarters since. The position peaked at $413M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Man Group held 1,774,415 shares of AbbVie worth $386M as of Q1 2026.
Man Group sold 34,292 AbbVie shares in Q1 2026, an estimated $7.61M.
AbbVie made up 0.7% of Man Group's portfolio in Q1 2026, its #12 holding.
Man Group first reported a position in AbbVie in Q1 2018 and has held it in 30 quarters since.
Man Group's AbbVie position peaked at $413M in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.